Summary
Synopsys Inc. (SNPS) reported strong financial results for the quarter ended January 31, 2021, with total revenue increasing by 16% year-over-year to $970.3 million. This growth was driven by both the Semiconductor & System Design segment, which saw a 17% increase in revenue, and the Software Integrity segment, which grew by 7%. The company demonstrated robust profitability, with operating income rising significantly by 70% to $148.3 million, and net income attributed to Synopsys increasing to $162.3 million from $104.1 million in the prior year period. Diluted earnings per share improved to $1.03. The company's balance sheet remains solid, with total assets of $8.01 billion and total liabilities of $3.13 billion. Cash and cash equivalents stood at $1.02 billion, although this represents a decrease from the previous quarter, primarily due to significant share repurchase activities. The company also executed an accelerated share repurchase agreement for $250.0 million during the quarter. Synopsys continues to invest in research and development, which increased by 14% year-over-year, underscoring its commitment to innovation in the dynamic semiconductor and software security markets.
Financial Highlights
57 data points| Revenue | $970.32M |
| Cost of Revenue | $208.00M |
| Gross Profit | $762.32M |
| R&D Expenses | $357.47M |
| Operating Expenses | $613.97M |
| Operating Income | $148.35M |
| Interest Expense | $739K |
| Net Income | $162.34M |
| EPS (Basic) | $1.06 |
| EPS (Diluted) | $1.03 |
| Shares Outstanding (Basic) | 152.50M |
| Shares Outstanding (Diluted) | 157.28M |
Key Highlights
- 1Total revenue increased by 16% year-over-year to $970.3 million.
- 2Operating income surged by 70% to $148.3 million, indicating strong operational leverage.
- 3Net income attributed to Synopsys grew substantially to $162.3 million, up from $104.1 million in the prior year.
- 4Diluted earnings per share improved to $1.03 from $0.67 in the same period last year.
- 5The Semiconductor & System Design segment revenue grew by 17%, driven by ongoing organic growth.
- 6Despite a planned decrease in cash due to share repurchases, the company maintains a healthy cash position of $1.02 billion.
- 7Research and Development expenses increased by 14% to $357.5 million, reflecting continued investment in innovation.